Assessment of effectiveness of oral vitamin D3 on Bacterial vaginosis in women in fertility ages

Vice chancellor for research, Tehran University of Medical sciences0 个研究点目标入组 190 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•Ages 18-35; Stability in medical condition among 6 months later; Lack of Pathological obesity; Not using tobacco; Lack of history of hypercalcemia, nephrolitiasis or sarcoidosis; Lack of current pregnancy; Lack of recent history of hospitalization; Absence of liver or kidney disorder; current malignancy or malabsorption; Lack of immune suppression, or those drugs that will interfere with vitamin D metabolism, such as phenytoin and carbamazepine; Not taking vitamin D supplements meet; Lack of clinical bacterial vaginosis; Lack of normal amounts of vitamin D in first assessment; Detection of asymptomatic bacterial vaginosis with nugent test
•Exclusion criteria: Unwillingness to continue the use of drug; pregnancy occurred; Drug allergy symptoms such as gastrointestinal symptoms; Vaginal infection symptoms like foul-smelling discharge; Use of drug non according to the pharmacist recommendation

发起方

Vice chancellor for research, Tehran University of Medical sciences